trastuzumab
Not Tagged
['trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)', 'breast']
 meanwhile also presented at #asco23 is 10 year data where for her2 driven breast there is a 93% posterior probability that 9 weeks trastuzumab is non-inferior to 1 year. 5 year data showed ~2/3 risk reduction in cardiac events with less - but no interest in de-escalation there
Oncologist | RadOnc | Stats #Rstats | Opinion | Politics | Never Trump